Prelude Capital Management, LLC Olema Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $358,065 - $543,474	32,700 New	32,700 $370,000
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $9,501 - $18,518	-3,726 Reduced 18.68%	16,225 $56,000
Q4 2022 Feb 14, 2023	BUY	$2.27 - $3.76 $2,724 - $4,512	1,200 Added 6.4%	19,951 $48,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $25,176 - $54,425	-9,256 Reduced 33.05%	18,751 $52,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.61 $27,986 - $63,244	13,719 Added 96.02%	28,007 $114,000
Q1 2022 May 16, 2022	BUY	$3.89 - $9.43 $55,580 - $134,735	14,288 New	14,288 $61,000

146

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $204M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.